Mobile CenteringPregnancy for Prenatal Care
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method of providing prenatal care for Marshallese women using a group model called Mobile CenteringPregnancy. The goal is to determine if this approach can improve birth outcomes, such as reducing preterm births and low birth weight, by offering prenatal care directly in the community. Pregnant women (12-14 weeks along) who identify as Marshallese may be suitable for this trial. The study aims to find effective methods to support better health for both mothers and babies, ultimately reducing the risk of childhood obesity. As an unphased trial, participants contribute to pioneering research that may enhance prenatal care for their community.
Will I have to stop taking my current medications?
If you are taking medications that can affect fetal growth, like glucocorticoids, insulin, or thyroid hormones, you may not be eligible for this trial. It's best to discuss your current medications with the trial team to see if you can participate.
What prior data suggests that the Mobile CenteringPregnancy program is safe for prenatal care?
Research has shown that group prenatal care, such as the Mobile CenteringPregnancy model, is generally well-received. Women participating in this type of care often experience fewer early births and have healthier babies. One study found that women in group prenatal care were less likely to have premature births. Another study demonstrated that these group sessions improve mothers' health and foster trust and confidence among families.
Overall, strong evidence indicates that group prenatal care is safe and beneficial for both mothers and their babies.12345Why are researchers excited about this trial?
Researchers are excited about Mobile CenteringPregnancy because it offers a fresh take on prenatal care through group sessions rather than traditional one-on-one visits. This method brings together pregnant women with similar due dates to share their experiences, providing emotional support and fostering a sense of community. Studies have shown that this group approach can lead to healthier outcomes, such as reduced rates of preterm births and low birth weight, as well as improved maternal mental health and satisfaction. By incorporating mobile health clinics, this approach also makes accessing care more convenient, especially for those in underserved areas.
What evidence suggests that Mobile CenteringPregnancy is effective for improving prenatal care outcomes for Pacific Islanders?
Research has shown that CenteringPregnancy, a group prenatal care model, effectively lowers the chances of early births and underweight babies. In a large study, this care reduced the risk of early birth by 33%. It also improves mothers' mental health, increases breastfeeding rates, and supports healthy weight gain during pregnancy. These benefits lead to better health for both mothers and babies. In this trial, participants will receive group prenatal care through mobile health clinics, aiming to bring these positive effects directly to communities in need, such as the Marshallese community.36789
Are You a Good Fit for This Trial?
This trial is for Marshallese women in Arkansas who are at least 18 years old and pregnant (12-14 weeks gestation confirmed with ultrasound). It aims to improve maternal and infant health outcomes, particularly addressing high rates of preterm birth and low birthweight among this community.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prenatal Care
Participants attend routine one-on-one prenatal appointments prior to the intervention
Group Prenatal Care
Participants engage in group prenatal care sessions from week 14 of pregnancy through birth
Follow-up
Participants are monitored for preterm birth and maternal health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Mobile CenteringPregnancy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arkansas
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute of General Medical Sciences (NIGMS)
Collaborator